Beranda › Meduloblastoma › Texas
Uji klinis Meduloblastoma di Texas
8 studi untuk Meduloblastoma mencari peserta di lokasi di Texas.
Kota di Texas
Teks studi resmi (Bahasa Inggris)
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- UT Southwestern Medical Center/Harold C Simmons Comprehensive Cancer Center, Dallas
- Cook Children's Medical Center, Fort Worth
- Texas Children's Hospital, Houston
Menerima pesertaFase 2
59 Months · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT05535166Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
- Dell Children's Medical Group SFC-HEM/ONC, Austin
Menerima pesertaFase 2
Hingga usia 19 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT01356290HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- MD Anderson Cancer Center, Houston
Menerima pesertaFase 1
36 Months – 22 Years · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT03911388Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry Study
- Baylor College of Medicine, Houston
- MD Anderson Cancer Center, Houston
Menerima pesertaStudi observasional
Usia 3 hingga 50 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT07242963Digoxin Medulloblastoma Study
- UT Southwestern, Dallas
Menerima pesertaFase 2
12 Months – 30 Years · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT06701812A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Dell Children's Medical Center of Central Texas, Austin
- Driscoll Children's Hospital, Corpus Christi
- Medical City Dallas Hospital, Dallas
- dan 4 lainnya
Menerima pesertaFase 3
Usia 4 hingga 21 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT05382338PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Texas Children's Hospital, Houston
Menerima pesertaFase 2
Usia 3 hingga 39 · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT05096481DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- Dell Children's Blood and Cancer Center, Austin
Menerima pesertaFase 2
Hingga usia 21 · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT04696029Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.